Keyword: National Pharmaceutical Council
In a healthcare system "designed to obfuscate," it's going to take collaboration to lower costs for patients, experts say.
As the rest of the healthcare industry continues to move towards value, drugmakers are doing the same in the form of private contracts.
ACOs can optimize medications to meet quality standards, but some face barriers to such efforts, a new study found.
Health plans are taking a broad approach to health data, using digital records to drive value-based contracts and improve population health.